ChromaDex
CDXC
$3.30
Share price
-5.17%
Change (1 day)
112.90%
Change (1 year)
Categories
ChromaDex (CDXC) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $26.5 M
According to ChromaDex's latest financial reports the company's total liabilities are $26.5 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ChromaDex - Total liabilities on balance sheet (from 2007 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $26.5 M | 4.42% |
| 2022-12-31 | $25.38 M | -2.79% |
| 2021-12-31 | $26.11 M | 19.05% |
| 2020-12-31 | $21.93 M | 10.77% |
| 2019-12-31 | $19.8 M | 31.54% |
| 2018-12-31 | $15.05 M | 69.34% |
| 2017-12-31 | $8.89 M | -9.08% |
| 2016-12-31 | $9.77 M | -27.44% |
| 2015-12-31 | $13.47 M | 79.22% |
| 2014-12-31 | $7.51 M | 126.36% |
| 2013-12-31 | $3.32 M | -34.11% |
| 2012-12-31 | $5.04 M | 35.93% |
| 2011-12-31 | $3.7 M | 136.04% |
| 2010-12-31 | $1.57 M | -37.59% |
| 2009-12-31 | $2.51 M | 7.87% |
| 2008-12-31 | $2.33 M | |
| 2007-11-30 | $0 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sangamo Therapeutics
SGMO | $82.43 M | 210.97% | 🇺🇸 USA |
 Exelixis EXEL | $0.67 B | 2,449.21% | 🇺🇸 USA |